Point-of-Care Vestibular Testing

Vestibular assessment support,
in the palm of your hand.

SmartVertigo™ is a portable, smartphone-based system designed to help clinicians record, review, and document eye movements during positional vestibular testing.

RecordReviewDocument
Request a Demo About VertigoDx How It Works
About VertigoDx

Portable technology for clinician-led vestibular assessment.

VertigoDx, Inc. develops SmartVertigo™, a smartphone-based headset and mobile application intended to capture close-up eye movement video during positional vestibular testing.

The system is designed to support:

  • Clinician review
  • Documentation
  • Patient education
  • Continuity of care

Clinical interpretation, diagnosis, and treatment decisions remain the responsibility of the licensed healthcare professional.

01

Who We Are

VertigoDx is a medical technology company focused on practical tools for vestibular evaluation in clinics, emergency care settings, and rehabilitation environments.

02

What We Do

SmartVertigo™ helps clinicians visualize, record, replay, and document eye movements observed during standardized positional testing.

03

Patent Status

SmartVertigo™ is patent pending, including a worldwide PCT patent application and related provisional patent filings.

How It Works

Three steps to point-of-care positional testing.

Portable eye-movement recording and playback to support clinician review and documentation at the point of care.

01

Fit the Headset

Place the SmartVertigo™ headset on the patient. Built-in optics block ambient light — no darkroom needed.

02

Run the Exam

Perform standardized positional tests used by clinicians when evaluating suspected BPPV and related vestibular complaints.

03

Review the Results

Eye movement recordings are available immediately for clinician review, playback, and documentation.

Point-of-Care Recording

Close-up eye movement video, captured during positional testing.

Recorded through the SmartVertigo™ headset for clinician review, playback, and documentation.

Leadership

Who we are and what we do.

Dr. Paul Louis

Dr. Paul Louis, MD

Chief Executive Officer

Emergency medicine physician who joined VertigoDx as Chief Executive Officer to help advance point-of-care vestibular assessment technology.

Trevor Meyerowitz

Trevor Meyerowitz, PT

Chief Medical Officer

Physical Therapist for over 36 years specializing in vertigo and vestibular rehabilitation.

Stephen Meyerowitz

Stephen Meyerowitz

Chief Technology Officer

Engineering lead responsible for the SmartVertigo™ hardware platform, mobile application, and product development.

Alan Keschner

Alan Keschner

Chief Financial Officer

Financial executive supporting healthcare operations, business planning, and medical device company development.

Get in Touch

Request a demo.

Fill in your details and a member of our team will be in touch.

Patent and FDA Status
Patent Pending — Worldwide PCT Under FDA Review Not Yet FDA Cleared

SmartVertigo™ is patent pending, including a worldwide PCT patent application and related provisional patent filings.

SmartVertigo™ is currently under review by the U.S. Food and Drug Administration (FDA) and has not yet received FDA clearance. SmartVertigo™ is intended for use only where permitted by applicable laws and regulations until such clearance is obtained.